Phillips DR - Search Results

1

Platelet-derived CD40L: the switch-hitting player of cardiovascular disease.

André P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. André P, et al. Among authors: phillips dr. Circulation. 2002 Aug 20;106(8):896-9. doi: 10.1161/01.cir.0000028962.04520.01. Circulation. 2002. PMID: 12186789 No abstract available.

2

Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation.

Nannizzi-Alaimo L, Alves VL, Phillips DR. Nannizzi-Alaimo L, et al. Among authors: phillips dr. Circulation. 2003 Mar 4;107(8):1123-8. doi: 10.1161/01.cir.0000053559.46158.ad. Circulation. 2003. PMID: 12615789

3

Cardiopulmonary bypass induces release of soluble CD40 ligand.

Nannizzi-Alaimo L, Rubenstein MH, Alves VL, Leong GY, Phillips DR, Gold HK. Nannizzi-Alaimo L, et al. Among authors: phillips dr. Circulation. 2002 Jun 18;105(24):2849-54. doi: 10.1161/01.cir.0000019068.32280.b3. Circulation. 2002. PMID: 12070112

4

The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease.

Prasad KS, Andre P, Yan Y, Phillips DR. Prasad KS, et al. Among authors: phillips dr. Curr Opin Hematol. 2003 Sep;10(5):356-61. doi: 10.1097/00062752-200309000-00006. Curr Opin Hematol. 2003. PMID: 12913790 Review.

5

Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis.

André P, LaRocca T, Delaney SM, Lin PH, Vincent D, Sinha U, Conley PB, Phillips DR. André P, et al. Among authors: phillips dr. Circulation. 2003 Nov 25;108(21):2697-703. doi: 10.1161/01.CIR.0000093279.36628.12. Epub 2003 Nov 3. Circulation. 2003. PMID: 14597584

6

Effect of Ca2+ on GP IIb-IIIa interactions with integrilin: enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate.

Phillips DR, Teng W, Arfsten A, Nannizzi-Alaimo L, White MM, Longhurst C, Shattil SJ, Randolph A, Jakubowski JA, Jennings LK, Scarborough RM. Phillips DR, et al. Circulation. 1997 Sep 2;96(5):1488-94. doi: 10.1161/01.cir.96.5.1488. Circulation. 1997. PMID: 9315536

7

CD40L stabilizes arterial thrombi by a beta3 integrin--dependent mechanism.

André P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD. André P, et al. Among authors: phillips dr. Nat Med. 2002 Mar;8(3):247-52. doi: 10.1038/nm0302-247. Nat Med. 2002. PMID: 11875495

8

GP IIb/IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention.

Welt FG, Rogers SD, Zhang X, Ehlers R, Chen Z, Nannizzi-Alaimo L, Phillips DR, Simon DI. Welt FG, et al. Among authors: phillips dr. Catheter Cardiovasc Interv. 2004 Feb;61(2):185-9. doi: 10.1002/ccd.10763. Catheter Cardiovasc Interv. 2004. PMID: 14755809

9

Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling.

Prasad KS, Andre P, He M, Bao M, Manganello J, Phillips DR. Prasad KS, et al. Among authors: phillips dr. Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12367-71. doi: 10.1073/pnas.2032886100. Epub 2003 Sep 30. Proc Natl Acad Sci U S A. 2003. PMID: 14519852 Free PMC article.

10

Integrin tyrosine phosphorylation in platelet signaling.

Phillips DR, Prasad KS, Manganello J, Bao M, Nannizzi-Alaimo L. Phillips DR, et al. Curr Opin Cell Biol. 2001 Oct;13(5):546-54. doi: 10.1016/s0955-0674(00)00250-7. Curr Opin Cell Biol. 2001. PMID: 11544022 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

445 results

Search Page